Nolpitantium Besylate In Patients With Ulcerative Colitis a Double-Blind, Placebo Controlled Efficacy and Safety Study

Clinical trial NCT00232258 · COMPLETED

Trial details

NCT number: NCT00232258
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Ulcerative Colitis Inflammatory Bowel Disease

Start date: 2005-04-01
Primary completion: 2006-09-01
Enrollment: 307

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.